Strategic Targeting for Optimal Prevention of Cancer
- Age
- 65 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120,000 (estimated)
- Sponsor
- ClinLogic LLC · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Loading trial locations…